ADCs and Eye care

Dry eye or blurred vision? A patient’s cancer treatment may be part of the picture. Dr. Jeff Varanelli, OD, discusses antibody-drug conjugates (ADCs) and why they should be on every optometrist’s radar—from recognizing ocular side effects to knowing the specific medication a patient is receiving. Baseline exams, ongoing monitoring, and communication with oncology all matter. Watch for the key takeaways for your practice. #iDSocial #Optometry #EyeCare #OcularSurface #CancerCare